|
By Nono Hu, Senior Manager, Branding & Messaging, LSN
 At the third Redefining Early Stage Investments (RESI) Conference, LSN brought together experts from six major corporate venture funds that are involved in the early stage life science arena. The speakers shared examples of their recent investments and detailed their investment interests. The panelists also answered a variety of questions, including: What is your take on the resurgence of early stage pharmaceutical investment? How should I approach a corporate VC investor? Do corporate venture funds outperform VC firms, large pharmas, and other sources of investment? What is your advice for scientist-entrepreneurs?
Click on the video link below to hear the views of major players in the life science industry
 | |
RESI 3 Corporate Venture Capital Panel
|
READ MORE |
|
The research team at Life Science Nation is constantly identifying, interviewing, and profiling investors in the life science space. From Boston to Hong Kong, we leave no stone unturned in our efforts to uncover a variety of investors. This article shares some sources and tactics that we use to initially identify life science investors across the globe.
Investment Conferences: A great way to begin a search is by scouring the lists of attendees and speakers for various life science investment conferences. Investors who recently attended these types of events tend to be actively seeking new opportunities and therefore are ideal prospects for your campaign. With life science investment and partnering conferences taking place year-round and worldwide, there are a lot of potential investors to be uncovered...
|
|
By Lucy Parkinson, Senior Research Manager, LSN
 At LSN, we track both life science companies and life science investors located all over the world. We frequently stress that if you're seeking capital in the life science field, you will have more success if you reach out beyond your own backyard and market your opportunity to global investors. Nowhere is this more apparent than in Asia, where a history of concentrated R&D funding has resulted in the flowering of new biotech start-ups in the region.
The LSN Company Platform tracks thousands of life science companies across Asia. As shown in Exhibit 1, some of these are contract research organizations, suppliers, and other outsourcing partners, but many are companies developing innovative biotechnology or medical technology products...
|
Life Science Investor Mandates 
